Skip to content
Sign in
Angel networkBacked 1 network startup

JumpStart NJ Angel Network

US angel network investing at pre-seed and seed; backed Vytala Health's $805K pre-seed in medical nutrition.

United States
Ticket
—Not published
Assets under management
—
Founded
—
Stages
Pre-seedto Seed
Network startups backed
1
Co-investors
4most often with Delaware Crossing Investment Group

How they invest

Early-stage US companies; the name implies a New Jersey focus (not stated in our record). Network deal is clinical nutrition.

Stage and ticket

Pre-seed and seed.

Geography

Not listed; New Jersey presumably (name).

What makes them say yes

  • US pre-seed/seed with regional (NJ/Mid-Atlantic) link
  • Health and life-science products
  • Angel-syndicate-friendly rounds

Red flags

  • No regional link (inferred)
  • Large institutional rounds

Sectors

Not published

Stages

  • Pre-seed
  • Seed

Geographies

Not published

How to approach

Ask Vytala Health's founders for a referral to the screening committee.

Portfolio

1 network startup · no other company

Vytala Health alongside Robin Hood Ventures, Delaware Crossing and Ulu Ventures — Mid-Atlantic angel syndicate.

Gaps in the portfolio

  • Medtech
  • Digital health

Network startups

  • Vytala HealthSWC 2026 Finalist

    Plant-based medical food Seracal using a structured lipid matrix to improve fat and nutrient absorption in malabsorption patients.

    United States · Agri & FoodTech

    • pre-seed (initial closing) · $805K · 1 Sept 2024Source

Network startups that fit

4 analysed

Nurse-practitioner-founded device start-up designing a multi-drug emergency IV pump with protocol-guided dosing safeguards.

US pre-seed emergency IV pump — health device at angel stage.

30%confidence

Evidence from the records

  • “"Pre-seed","Seed"”
  • “Multi-drug emergency IV pump”
  • “No public evidence of traction found: pump shown as a concept visual”
Intro path
Founder-to-founder intro via Vytala Health (network portfolio company of JumpStart NJ Angel Network).
First step
Ask Vytala for a referral.

Smartphone eyelid-photo AI that screens for anemia in seconds without a blood draw, aimed at low-resource care.

US pre-seed AI anemia detection — angel-stage health.

30%confidence

Evidence from the records

  • “Vytala Health”
  • “AI anemia detection”
  • “NiADA app (analysis of a smartphone photo of the lower eyelid) available on Google Play and Apple TestFlight”
Intro path
Founder-to-founder intro via Vytala Health (network portfolio company of JumpStart NJ Angel Network).
First step
Ask Vytala for a referral.

Physician-led Kansas medtech developing UniPen, a universal vial-compatible self-injection pen aimed at cutting pharma device costs and lead times.

US pre-seed self-injection devices — angel-stage medtech.

25%confidence

Evidence from the records

  • “Vytala Health”
  • “Self-injection devices”
  • “UniPen available through licensed pharmacies (not FDA-authorized)”
Intro path
Founder-to-founder intro via Vytala Health (network portfolio company of JumpStart NJ Angel Network).
First step
Check NJ presence first.

Preclinical biotech licensing University of Miami RNA aptamers to regenerate beta cells in type 1 diabetes and target solid tumours.

US pre-seed aptamer therapeutics — biotech, very early.

20%confidence

Evidence from the records

  • “Vytala Health”
  • “RNA aptamers – type 1 diabetes and solid tumors”
  • “No public evidence of traction found: preclinical RNA aptamer pipeline.”
Intro path
Founder-to-founder intro via Vytala Health (network portfolio company of JumpStart NJ Angel Network).
First step
Low priority.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Delaware Crossing Investment Group, Robin Hood Ventures, and The MBA Fund

Sources

  1. 1biospace.com/press-releases/vytala-inc-debuts-with-initial-close-of-pre-

Profile compiled from public sources. Unknown fields are left empty rather than estimated.